lobbying_activities: 3009952

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3009952	d8e5c3bf-e563-4abf-bfeb-687140005f38	Q2	COUNCIL FOR RESPONSIBLE NUTRITION	11036	COUNCIL FOR RESPONSIBLE NUTRITION	2023	second_quarter	CSP	Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to nutritional access for undeserved populations. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. General issues related to the dietary supplements industry.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		120000	0	0	2023-07-18T12:23:12-04:00